📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A rapid rise in circulating pancreastatin in response to somatostatin analogue therapy is associated with poor survival in patients with neuroendocrine tumours (2008)

First Author: Stronge R

Attributed to: The Centre of Excellence for Public Health (Northern Ireland) funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1258/acb.2008.008033

PubMed Identifier: 18782815

Publication URI: http://europepmc.org/abstract/MED/18782815

Type: Journal Article/Review

Parent Publication: Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Issue: 6

ISSN: 0004-5632